Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized , Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa

NCT03852472 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT03852472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03852472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized , Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
December 21, 2018
Completion date
March 9, 2021
Enrollment
435 (actual)
Sites
91

Conditions

As the registry lists them; a condition with its own page is linked.

acne inversa, hidradenitis suppurativa